Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Pharmacy
Published in: International Journal of Clinical Pharmacy 5/2009

01-10-2009 | Commentary

Prevention of wrong route errors in a pediatric hemato-oncology ward

Authors: Tiene Bauters, Johan De Porre, Nicky Janssens, Véronique Van de Velde, Joris Verlooy, Catherine Dhooge, Hugo Robays

Published in: International Journal of Clinical Pharmacy | Issue 5/2009

Login to get access

Abstract

Three consecutive wrong route administration errors are described in detail and the ease by which enteral preparations can be given by the wrong route is discussed. By introducing the use of purple oral liquid dispensers in our pediatric department, we hope to prevent and reduce the risk of similar medications errors in the future and to improve patients safety.
Literature
1.
2.
Joint Commission on Accreditation of Healthcare Organizations. Tubing misconnections: a persistent and potentially deadly occurrence. Sentinel Event Alert. 2006;36:1–3.
3.
Page L. Finding the wrong fit. Mater Manag Health Care. 2006;15(4):24–8.
4.
Pratt N. Tubing misconnections: a perilous design flaw. Mater Manag Health Care. 2006;15(11):36–9.PubMed
5.
Bridge L. Reducing the risk of wrong route errors. Paediatric Nurs. 2007;19(6):33–5.CrossRef
6.
Pope M. A mix-up of tubes. Medication administered through the wrong access line. Am J Nurs. 2002;102(4):23.CrossRefPubMed
7.
Roberts TC, Swart M. Enteral drugs given through a central venous catheter. Anaesthesia. 2007;62(6):624–6.CrossRef
8.
Metadata
Title
Prevention of wrong route errors in a pediatric hemato-oncology ward
Authors
Tiene Bauters
Johan De Porre
Nicky Janssens
Véronique Van de Velde
Joris Verlooy
Catherine Dhooge
Hugo Robays
Publication date
01-10-2009
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 5/2009
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-009-9319-7

Other articles of this Issue 5/2009

International Journal of Clinical Pharmacy 5/2009 Go to the issue

Commentary

Organisational culture: an important concept for pharmacy practice research

Commentary

Current issues around the pharmacotherapy of ADHD in children and adults

Erratum

Erratum to: Professional ethics in pharmacy practice: developing a psychometric measure of moral reasoning

Research Article

Patient self-reporting of potential adverse drug reactions to non-steroidal anti-inflammatory drugs in Thailand

Review Article

Measurement of patient satisfaction with community pharmacy services: a review

OriginalPaper

Pharmaceutical care for patients with ischemic stroke: improving the patients quality of life
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits